Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study

Penn-Nicholson, A; Hraha, T; Thompson, EG; Sterling, D; Kimbung Mbandi, S; Wall, K; Fisher, M; Suliman, S; Shankar, S; Hanekom, WA; Janjic, N; Hatherill, M; Kaufmann, SH; Sutherland, JORCID logo; Walzl, G; De Groote, MA and Ochsner, U (2019). Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. [Dataset]. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002781.s007
Copy

A nonsputum blood test capable of predicting progression of healthy individuals to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment to curb transmission. We aimed to develop a proteomic biomarker of risk of TB progression for ultimate translation into a point-of-care diagnostic.

Keywords

findings Proteomic TB risk signatures; TB disease; prognostic proteomic signature; Prognostic performance; 3 PR signature

No files available. Please consult associated links.


Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core (with Type as Type) MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON METS MODS RDF+N3 RDF+N-Triples RDF+XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export